By Keith Goldberg ( March 14, 2013, 4:48 PM EDT) -- The U.S. Food and Drug Administration said Thursday that it would investigate a new report claiming a class of diabetes drugs, including ones manufactured by drug giants such as Merck & Co. Inc., Bristol-Myers Squibb Co. and AstraZeneca PLC, may cause precancerous changes in the pancreas....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.